Plant ID: NPO9839
Plant Latin Name: Polanisia Dodecandra
Taxonomy Genus: Polanisia
Taxonomy Family: Cleomaceae
NCBI TaxonomyDB:
72660
Plant-of-the-World-Online:
n.a.
Mexico
Ingredient ID: NPC9609
Ingredient ID: NPC9202
Ingredient ID: NPC81074
Ingredient ID: NPC72675
Ingredient ID: NPC71460
Ingredient ID: NPC70064
Ingredient ID: NPC65225
Ingredient ID: NPC64500
Ingredient ID: NPC61762
Ingredient ID: NPC53002
Ingredient ID: NPC45258
Ingredient ID: NPC4481
Ingredient ID: NPC41291
Ingredient ID: NPC35596
Ingredient ID: NPC32230
Ingredient ID: NPC31618
Ingredient ID: NPC311690
Ingredient ID: NPC304309
Ingredient ID: NPC301204
Ingredient ID: NPC291158
Ingredient ID: NPC28657
Ingredient ID: NPC26744
Ingredient ID: NPC240868
Ingredient ID: NPC238950
Ingredient ID: NPC237946
Ingredient ID: NPC226941
Ingredient ID: NPC226813
Ingredient ID: NPC216420
Ingredient ID: NPC214199
Ingredient ID: NPC2110
Ingredient ID: NPC200517
Ingredient ID: NPC19687
Ingredient ID: NPC192501
Ingredient ID: NPC191089
Ingredient ID: NPC181516
Ingredient ID: NPC171545
Ingredient ID: NPC16449
Ingredient ID: NPC160719
Ingredient ID: NPC158208
Ingredient ID: NPC157192
Ingredient ID: NPC134847
Ingredient ID: NPC111289
Target Type | Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|---|
Cytochrome P450 | Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 | Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Therapeutic Target | Hydrolase | RAB9A | Ras-related protein Rab-9A | P51151 | CHEMBL1293294 |
Therapeutic Target | Methyl-lysine/arginine binding protein | SMN1 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | RORC | Nuclear receptor ROR-gamma | P51449 | CHEMBL1741186 |
Therapeutic Target | Nuclear hormone receptor subfamily 1 | NR1H3 | LXR-alpha | Q13133 | CHEMBL2808 |
Therapeutic Target | Nuclear hormone receptor subfamily 3 | NR3C1 | Glucocorticoid receptor | P04150 | CHEMBL2034 |
Therapeutic Target | Secreted protein | THPO | Thrombopoietin | P40225 | CHEMBL1293256 |
Drug Transporter | SLC superfamily of solute carriers | SLC22A3 | Solute carrier family 22 member 3 | O75751 | CHEMBL2073673 |
Therapeutic Target | Structural protein | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
Therapeutic Target | Transcription factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Therapeutic Target | Transcription factor | PAX8 | Paired box protein Pax-8 | Q06710 | CHEMBL2362980 |
Therapeutic Target | Transporter | NPC1 | Niemann-Pick C1 protein | O15118 | CHEMBL1293277 |
Therapeutic Target | Unclassified protein | GMNN | Geminin | O75496 | CHEMBL1293278 |
Clinical trials associated with plant from natural product (NP) & plant level:
Clinical trials type | Number of clinical trials | |
---|---|---|
NP level | 89 | |
NCT ID | Title | Condition | Form in clinical use | Associated by plant or compound |
---|---|---|---|---|
NCT04355143 | Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) | COVID-19 | Colchicine (NPC226941) | NP level |
NCT05324423 | To Evaluate Drug Interactions Between XNW3009, Febuxostat, and Colchicine in Patients With Gout | gout | Colchicine (NPC226941) | NP level |
NCT05159219 | Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage | intracranial hemorrhage | Colchicine (NPC226941) | NP level |
NCT04350320 | Trial to Study the Benefit of Colchicine in Patients With COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
NCT05250596 | COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS) | acute coronary syndrome | Colchicine (NPC226941) | NP level |
NCT00965068 | Cholesterol in ASD: Characterization and Treatment | Asperger syndrome;autism | Cholesterol (NPC28657) | NP level |
NCT04916522 | The COlchicine HypERtENsion Trial | hypertension | Colchicine (NPC226941) | NP level |
NCT02366091 | Inflammation and Coronary Endothelial Function | coronary artery disease | Colchicine (NPC226941) | NP level |
NCT00128414 | Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode) | pericarditis | Colchicine (NPC226941) | NP level |
NCT04756128 | Impact of Colchicine and Low-dose Naltrexone on COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
NCT04392141 | Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
NCT04762771 | Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19) | COVID-19 | Colchicine (NPC226941) | NP level |
NCT03905759 | Prophylaxis Against Postoperative Atrial Fibrillation in Patients Undergoing On-pump CABG | atrial fibrillation | Colchicine (NPC226941) | NP level |
NCT03015831 | Effect of Low Dose ColchiciNe on the InciDence of POAF | atrial fibrillation | Colchicine (NPC226941) | NP level |
NCT04322565 | Colchicine Counteracting Inflammation in COVID-19 Pneumonia | coronavirus infectious disease;viral pneumonia | Colchicine (NPC226941) | NP level |
NCT02442921 | Colchicine for Diabetic Nephropathy Trial | diabetic nephropathy | Colchicine (NPC226941) | NP level |
NCT00819585 | A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study) | gout | Colchicine (NPC226941) | NP level |
NCT01481233 | Oral Colchicine in Men With Castrate Resistant Prostate Cancer | prostate cancer | Colchicine (NPC226941) | NP level |
NCT01075906 | Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients | familial Mediterranean fever | Colchicine (NPC226941) | NP level |
NCT05151614 | Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection | COVID-19 | Colchicine (NPC226941) | NP level |
NCT02139046 | Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout | gout | Colchicine (NPC226941) | NP level |
NCT02162303 | Colchicine in Vascular Inflammation Assessed With PET Imaging | vascular disease | Colchicine (NPC226941) | NP level |
NCT05472337 | Effect of Colchicine on Coronary Reperfusion in Patients With Acute Coronary Syndrome | acute coronary syndrome | Colchicine (NPC226941) | NP level |
NCT04324463 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | COVID-19;severe acute respiratory syndrome | Colchicine (NPC226941) | NP level |
NCT00009841 | Gene Therapy in Treating Patients With Advanced Head and Neck Cancer | head and neck malignant neoplasia | Cholesterol (NPC28657) | NP level |
NCT04264260 | Evaluation the Palliative Effects of Colchicine on Primary Hepatic Malignant Tumors Unable to Receive Curative Treatment | cholangiocarcinoma | Colchicine (NPC226941) | NP level |
NCT04603690 | Oral Curcumin, Quercetin and Vitamin D3 Supplements for Mild to Moderate Symptoms of COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
NCT04667780 | Study to Investigate the Treatment Effect of Colchicine in Patients With COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
NCT00000577 | Asthma Clinical Research Network (ACRN) | asthma;lung disease | Colchicine (NPC226941) | NP level |
NCT04360980 | The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection | COVID-19 | Colchicine (NPC226941) | NP level |
NCT00272844 | Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome | Smith-Lemli-Opitz syndrome | Cholesterol (NPC28657) | NP level |
NCT00128427 | Study of Colchicine to Prevent the Postpericardiotomy Syndrome | Postpericardiotomy Syndrome | Colchicine (NPC226941) | NP level |
NCT03693781 | Colchicine for Amyotrophic Lateral Sclerosis | amyotrophic lateral sclerosis | Colchicine (NPC226941) | NP level |
NCT03532776 | Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts | anogenital venereal wart | Podofilox (NPC237946) | NP level |
NCT02176460 | Colchicine for Symptom and Inflammation in Knee Osteoarthritis | osteoarthritis | Colchicine (NPC226941) | NP level |
NCT03048825 | Colchicine and Spironolactone in Patients With MI / SYNERGY Stent Registry | Non-ST Elevation Myocardial Infarction;ST Elevation Myocardial Infarction | Colchicine (NPC226941) | NP level |
NCT04328480 | The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. | COVID-19 | Colchicine (NPC226941) | NP level |
NCT04381936 | Randomised Evaluation of COVID-19 Therapy | severe acute respiratory syndrome | Colchicine (NPC226941) | NP level |
NCT05459974 | Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation | atrial fibrillation | Colchicine (NPC226941) | NP level |
NCT04367168 | Colchicine in Patients With Mild and Severe Coronavirus Disease | COVID-19 | Colchicine (NPC226941) | NP level |
NCT02330796 | Bucillamine for the Treatment of Acute Gout Flare in Subjects With Moderate to Severe Gout | gout | Colchicine (NPC226941) | NP level |
NCT04416334 | PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS | COVID-19 | Colchicine (NPC226941) | NP level |
NCT03021343 | Effect of Colchicine on the Incidence of Atrial Fibrillation in Open Heart Surgery Patients | cardiac arrhythmia | Colchicine (NPC226941) | NP level |
NCT00004368 | Phase I Study of Colchicine Therapy in Childhood Hepatic Cirrhosis | cirrhosis of liver | Colchicine (NPC226941) | NP level |
NCT04375202 | Colchicine in COVID-19: a Pilot Study | COVID-19 | Colchicine (NPC226941) | NP level |
NCT00754819 | Targeting Inflammation in Acute Coronary Syndrome Using Colchicine | acute coronary syndrome | Colchicine (NPC226941) | NP level |
NCT04130204 | Topical Application to Relieve Gout: Efficacy Trial & Safety (TARGETS) | gout | Colchicine (NPC226941) | NP level |
NCT01985425 | Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study | atrial fibrillation | Colchicine (NPC226941) | NP level |
NCT04492358 | Treatment for Moderate/Severe COVID-19 in a Fragile and Vulnerable Population, Admitted to a Geriatric Hospital Unit or in a Transicional Care Center | COVID-19 | Colchicine (NPC226941) | NP level |
NCT04500665 | Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine | chronic kidney disease | Colchicine (NPC226941) | NP level |
NCT04160117 | Impact of Short-course Colchicine Versus Placebo After Pulmonary Vein Isolation (IMPROVE-PVI Pilot) | atrial fibrillation | Colchicine (NPC226941) | NP level |
NCT04867226 | Effectiveness of Colchicine Among Patients With COVID-19 Infection | COVID-19 | Colchicine (NPC226941) | NP level |
NCT04322682 | Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) | COVID-19 | Colchicine (NPC226941) | NP level |
NCT04363437 | COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
NCT00700297 | Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease | Behcet's syndrome | Colchicine (NPC226941) | NP level |
NCT02060552 | Immune Molecular and Inflammatory Cytokines Dysfunction Analysis in Gout Patients With Different Urate Levels | gout | Colchicine (NPC226941) | NP level |
NCT02063997 | Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients | gout | Colchicine (NPC226941) | NP level |
NCT05118737 | Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia. | COVID-19 | Colchicine (NPC226941) | NP level |
NCT00840489 | Efficacy of Long-term Ribavirin in Non-responders With Chronic Hepatitis C and Advanced Fibrosis | chronic hepatitis C virus infection | Colchicine (NPC226941) | NP level |
NCT02500641 | Intensive Urate Lowering Therapy of Febuxostat Compared to Allopurinol on Cardiovascular Risk in Patients With Gout | gout | Colchicine (NPC226941) | NP level |
NCT02582190 | COlchicine for the Prevention of Post Electrical Cardioversion Recurrence of AF | atrial fibrillation | Colchicine (NPC226941) | NP level |
NCT04359823 | DSAP Treatment Comparison | porokeratosis | Cholesterol (NPC28657) | NP level |
NCT04472611 | Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial | COVID-19 | Colchicine (NPC226941) | NP level |
NCT01399008 | Safety/Efficacy Study to Evaluate of MBX-102 in Combination With Allopurinol in Gout Patients | gout | Colchicine (NPC226941) | NP level |
NCT04008316 | Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA Vasculitis | vasculitis | Colchicine (NPC226941) | NP level |
NCT04724629 | Survival TRial Using CytoKines in COVID-19 (STRUCK Trial) | COVID-19 | Colchicine (NPC226941) | NP level |
NCT04997551 | Double Blind Randomized Clinical Trial of Use of Colchicine Added to Standard Treatment in Hospitalized With Covid-19 | COVID-19 | Colchicine (NPC226941) | NP level |
NCT00128453 | Study of Colchicine to Treat Acute Pericarditis and Prevent Recurrences | pericarditis | Colchicine (NPC226941) | NP level |
NCT05175274 | Colchicine Use for Primary Prevention of Coronary Artery Disease | coronary artery disease | Colchicine (NPC226941) | NP level |
NCT01994226 | Colchicine Or Naproxen Treatment for ACute gouT | gout | Colchicine (NPC226941) | NP level |
NCT05279690 | Pilot Trial of Colchicine in Urothelial Cancer and Other Solid Tumors | neoplasm;urogenital neoplasm | Colchicine (NPC226941) | NP level |
NCT04539873 | Impact of Colchicine in Hospitalized Colombian Patients With COVID-19 | COVID-19 | Colchicine (NPC226941) | NP level |
NCT04359095 | Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia | COVID-19 | Colchicine (NPC226941) | NP level |
NCT00370760 | Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR) | proliferative vitreoretinopathy | Colchicine (NPC226941) | NP level |
NCT03575572 | Colchicine in Postoperative Fontan Patients | heart disease | Colchicine (NPC226941) | NP level |
NCT05503225 | Colchicine Use in Intracranial Atherosclerotic Disease | atherosclerosis | Colchicine (NPC226941) | NP level |
NCT02602028 | The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF | familial Mediterranean fever | Colchicine (NPC226941) | NP level |
NCT00004748 | Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis | primary biliary cirrhosis | Colchicine (NPC226941) | NP level |
NCT04870424 | Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement | atrial fibrillation | Colchicine (NPC226941) | NP level |
NCT00506883 | MPC-004 for the Treatment of an Acute Gout Flare | gout | Colchicine (NPC226941) | NP level |
NCT01755949 | Colchicine and CRP in Atrial Fibrillation and AF Ablation | atrial fibrillation | Colchicine (NPC226941) | NP level |
NCT03156816 | COlchicine for Left VEntricular Remodeling Treatment in Acute Myocardial Infarction | myocardial infarction | Colchicine (NPC226941) | NP level |
NCT04516941 | CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 | COVID-19;severe acute respiratory syndrome | Colchicine (NPC226941) | NP level |
NCT04420624 | COLchicine to Prevent Sympathetic Denervation After an Acute Myocardial Infarction | myocardial infarction | Colchicine (NPC226941) | NP level |
NCT01005121 | Colchicine for Diabetic Nephropathy | diabetic nephropathy | Colchicine (NPC226941) | NP level |
NCT04326790 | The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention | COVID-19 | Colchicine (NPC226941) | NP level |
NCT03131583 | The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout | gout | Colchicine (NPC226941) | NP level |
NCT04705987 | Randomized Double-blind Trial to Study the Benefit of Colchicine in Patients With Acutely Decompensated Heart Failure | heart failure | Colchicine (NPC226941) | NP level |
NCT00723268 | Evaluation of Therapeutic Effect of 0.5 mg Colchicine and 5 mg Prednisolone on Oral Aphthae | aphthous ulcer | Colchicine (NPC226941) | NP level |
How do we define the Plant-Targeted Human Disease Association?
Associated human diseases of an individual plant are summurized based on FOUR types of association evidence, these include:
❶ Association by Therapeutic Target: Bioactive protein targets of the plant were defined in "Molecular Targets" section, target-disease associations collected from TTD database were subsequently used to build the associations between the plant and its targeted human diseases.
❷ Association by Disease Gene Reversion: Plant and a specific disease will be associated when >= 1 plant target gene overlaped with disease's DEGs.
❸ Association by Clinical Trials of Plant: Plant and a specific disease will be associated when >= 1 clinical trial (the plant is the intervetion) can be matched in ClinicalTrials.gov database.
❹ Association by Clinical Trials of Plant Ingredients: Plant and a specific disease will be associated when >= 1 clinical trial (the plant ingredient is the intervetion) can be matched in ClinicalTrials.gov database.
Associated Disease of the Plant |
Association Type & Detailed Evidence |
---|---|
Atrial fibrillationDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC81.3 |
NCT02582190,NCT04160117,NCT01755949,NCT03015831,NCT03905759,NCT05459974,NCT04870424,NCT01985425
|
Diffuse large B-cell lymphomasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A81 |
NR1H3,TUBB6,PAX8,SMN1,THPO,SLC22A3,GMNN,LMNA
|
Adenocarcinoma of pancreasDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C10.0 |
TUBB6,PAX8,SLC22A3,NPC1,HIF1A,LMNA
|
Mesothelioma of pleuraDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C26.0 |
PAX8,SMN1,SLC22A3,NPC1,GMNN,LMNA
|
Malignant neoplasms of biliary tract, distal bile ductDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C15 |
TUBB6,PAX8,GMNN,HIF1A,LMNA
|
Solid tumour/cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00-2F9Z |
CYP3A4,HIF1A,RORC,NR3C1
|
Glioblastoma of brainDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00.00 |
TUBB6,GMNN,LMNA,RAB9A
|
Germ cell tumour of testisDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C80.2 |
SMN1,HIF1A,GMNN,RAB9A
|
Myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41-BA43 |
THPO
NCT03156816,NCT04420624 |
Atopic eczemaDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA80 |
NR3C1,NR3C1,CYP3A4
|
Severe acute respiratory syndromeDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D65 |
NCT04324463,NCT04381936,NCT04516941
|
Acute ischaemic heart disease, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA4Z |
NCT05472337,NCT05250596,NCT00754819
|
Carcinosarcoma of uterusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.43 |
PAX8,RORC,GMNN
|
Hepatocellular carcinoma of liverDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.02 |
PAX8,GMNN,GMNN
|
Superficial ovarian endometriosisDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GA10.B4 |
LMNA,RAB9A,TUBB6
|
Adenocarcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.0 |
GMNN,THPO,CYP2D6
|
Malignant neoplasms of adrenal glandDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D11 |
GMNN,CYP3A4,NR3C1
|
COVID-19Disease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D6Y |
NCT04359095,NCT04360980,NCT04756128,NCT04603690,NCT04326790,NCT04867226,NCT04472611,NCT04762771,NCT04350320,NCT05118737,NCT04416334,NCT04492358,NCT04516941,NCT04724629,NCT04539873,NCT04355143,NCT04367168,NCT04667780,NCT05151614,NCT04324463,NCT04997551,NCT04322682,NCT04363437,NCT04375202,NCT04392141,NCT04328480
|
AsthmaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA23 |
NR3C1
NCT00000577 |
Multiple sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8A40 |
NR3C1,RORC
|
Muscular atrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B61 |
SMN1,SMN2
|
Prostate cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C82 |
NR3C1
NCT01481233 |
Pulmonary hypertensionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB01 |
HIF1A
NCT04916522 |
Acute pericarditisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BB20 |
NCT00128453,NCT00128414
|
Chronic kidney disease, stage unspecifiedDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61.Z |
NCT02442921,NCT01005121
|
coronary artery diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA8Y-BA8Z |
NCT02366091,NCT05175274
|
Familial Mediterranean feverDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A60.0 |
NCT01075906,NCT02602028
|
Serous cystadenoma,borderline malignancy of ovaryDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C73.4 |
GMNN,RORC
|
PheochromocytomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH3854 |
NR3C1,RORC
|
Urothelial carcinoma of bladderDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C94.2 |
PAX8,CYP3A4
|
Malignant neoplasms of corpus uteri, unspecifiedDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C76.Z |
CYP2D6,PAX8
|
Chikungunya virus diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D40 |
HIF1A,LMNA
|
Malignant neoplasms of thymusDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C27 |
GMNN,CYP3A4
|
Renal cell carcinoma, chromophobe typeDisease Category: X.Extension CodesDisease ICD-11 Code: XH6153 |
CYP3A4,NPC1
|
Carpal tunnel syndromeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C10.0 |
TUBB6,THPO
|
GoutDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA25 |
NCT02139046,NCT02330796,NCT02063997,NCT01994226,NCT04130204,NCT00819585,NCT03131583,NCT00506883,NCT02500641,NCT01399008,NCT05324423,NCT02060552
|
Cushing syndromeDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A70 |
NR3C1
|
DepressionDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A70-6A7Z |
NR3C1
|
Chronic obstructive pulmonary diseaseDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA22 |
NR3C1
|
Lung cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25 |
RORC
|
Postoperative inflammationDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A00-CA43 |
NR3C1
|
Substance abuseDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6C40 |
NR3C1
|
Adrenogenital disorderDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A71 |
NR3C1
|
Herpes simplex infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F00 |
NR3C1
|
Mature T-cell lymphomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A90 |
HIF1A
|
Crohn diseaseDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD70 |
RORC
|
Breast cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C60-2C6Y |
NR3C1
|
RetinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B71 |
NR3C1
|
Type 2 diabetes mellitusDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A11 |
NR3C1
|
Mood disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A60-6E23 |
NR3C1
|
Allergic/hypersensitivity disorderDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A80-4A8Z |
NR3C1
|
Adrenomedullary hyperfunctionDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A75 |
HIF1A
|
Vasomotor/allergic rhinitisDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA08 |
NR3C1
|
Indeterminate colitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DD72 |
NR3C1
|
Vitamin deficiencyDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5B55-5B5F |
NR3C1
|
MalariaDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F40-1F45 |
CYP2D6
|
AnxietyDisease Category: 21.Symptoms, signs or clinical findings, not elsewhere classifiedDisease ICD-11 Code: MB24.3 |
CYP3A4
|
InsomniaDisease Category: 07.Sleep-wake disordersDisease ICD-11 Code: 7A00-7A0Z |
CYP2D6
|
Otitis externaDisease Category: 10.Diseases of the ear or mastoid processDisease ICD-11 Code: AA00-AA13 |
NR3C1
|
Ischaemic/haemorrhagic strokeDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B20 |
THPO
|
Acute diabete complicationDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5A2Y |
NR3C1
|
PsoriasisDisease Category: 14.Diseases of the skinDisease ICD-11 Code: EA90 |
RORC
|
Rheumatoid arthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA20 |
NR3C1
|
Fungal infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F29-1F2F |
RAB9A
|
Muscular dystrophyDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8C70 |
NR3C1
|
OesophagitisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA24 |
NR3C1
|
Spine/trunk injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: ND51 |
NR3C1
|
Adaptive immunity immunodeficiencyDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A01 |
NR3C1
|
Autoimmune diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A40-4A45 |
RORC
|
Brain cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2A00 |
HIF1A
|
NADisease Category: NADisease ICD-11 Code: NA |
NCT00000577
|
Coronary atherosclerosisDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA80 |
NCT05503225
|
Postcardiotomy syndromeDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BE10 |
NCT00128427
|
VitreoretinopathyDisease Category: 09.Diseases of the visual systemDisease ICD-11 Code: 9B78 |
NCT00370760
|
Behçet diseaseDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A62 |
NCT00700297
|
Coronavirus infectionDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D92 |
NCT04322565
|
Urogenital cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C95-2C9Z |
NCT05279690
|
Chronic kidney diseaseDisease Category: 16.Diseases of the genitourinary systemDisease ICD-11 Code: GB61 |
NCT04500665
|
Hepatic fibrosis/cirrhosisDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB93 |
NCT00004368
|
Disorders of cholesterol synthesisDisease Category: 05.Endocrine, nutritional or metabolic diseasesDisease ICD-11 Code: 5C52.10 |
NCT00272844
|
Acute non-ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.1 |
NCT03048825
|
Amyotrophic lateral sclerosisDisease Category: 08.Diseases of the nervous systemDisease ICD-11 Code: 8B60.0 |
NCT03693781
|
Chronic hepatitis CDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1E51.1 |
NCT00840489
|
Intracranial injuryDisease Category: 22.Injury, poisoning or certain other consequences of external causesDisease ICD-11 Code: NA07 |
NCT05159219
|
Cardiac arrhythmiaDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BC9Z |
NCT03021343
|
NeoplasmsDisease Category: 02.NeoplasmsDisease ICD-11 Code: 02 |
NCT05279690
|
Autism spectrum disorderDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02 |
NCT00965068
|
CholangiocarcinomaDisease Category: X.Extension CodesDisease ICD-11 Code: XH7M15 |
NCT04264260
|
Oral aphthae or aphtha-like ulcerationDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DA01.10 |
NCT00723268
|
Primary biliary cholangitis, unspecifiedDisease Category: 13.Diseases of the digestive systemDisease ICD-11 Code: DB96.1Z |
NCT00004748
|
Head and neck cancerDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2D42 |
NCT00009841
|
Viral pneumoniaDisease Category: 12.Diseases of the respiratory systemDisease ICD-11 Code: CA40.1 |
NCT04322565
|
Autism spectrum disorder without disorder of intellectual development and with mild or no impairment of functional languageDisease Category: 06.Mental, behavioural or neurodevelopmental disordersDisease ICD-11 Code: 6A02.0 |
NCT00965068
|
VasculitisDisease Category: 04.Diseases of the immune systemDisease ICD-11 Code: 4A44 |
NCT04008316
|
Anogenital wartsDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1A95 |
NCT03532776
|
Acute ST elevation myocardial infarctionDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA41.0 |
NCT03048825
|
Heart failureDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BD10-BD1Z |
NCT04705987
|
Diseases of the circulatory system, unspecifiedDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BE2Z |
NCT02162303
|
PorokeratosesDisease Category: 14.Diseases of the skinDisease ICD-11 Code: ED52 |
NCT04359823
|
Ischemic heart diseaseDisease Category: 11.Diseases of the circulatory systemDisease ICD-11 Code: BA40-BA6Z |
NCT03575572
|
OsteoarthritisDisease Category: 15.Diseases of the musculoskeletal system or connective tissueDisease ICD-11 Code: FA00-FA05 |
NCT02176460
|
HepatoblastomaDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C12.01 |
GMNN
|
LeishmaniasisDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1F54 |
NR1H3
|
Squamous cell carcinoma of bronchus or lungDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C25.2 |
GMNN
|
Tetralogy of FallotDisease Category: 20.Developmental anomaliesDisease ICD-11 Code: LA88.2 |
RORC
|
Other specified malignant neoplasms ofcolonDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2B90.Y |
SLC22A3
|
Cytomegaloviral diseaseDisease Category: 01.Certain infectious or parasitic diseasesDisease ICD-11 Code: 1D82 |
THPO
|
Invasive carcinoma of breastDisease Category: 02.NeoplasmsDisease ICD-11 Code: 2C61 |
THPO
|